265 related articles for article (PubMed ID: 24676623)
21. Outcomes after primary intensity-modulated radiation therapy for oropharyngeal squamous cell carcinoma at a New Zealand regional cancer centre: Impact of p16 status.
Maqsood S; Jameson MB; De Groot C; Hartopeanu C; Yasin NABHM; Thotathil Z
Cancer Rep (Hoboken); 2018 Jun; 1(1):e1001. PubMed ID: 32729235
[TBL] [Abstract][Full Text] [Related]
22. Prediction of concurrent chemoradiotherapy outcome in advanced oropharyngeal cancer.
Hasegawa M; Maeda H; Deng Z; Kiyuna A; Ganaha A; Yamashita Y; Matayoshi S; Agena S; Toita T; Uehara T; Suzuki M
Int J Oncol; 2014 Sep; 45(3):1017-26. PubMed ID: 24969413
[TBL] [Abstract][Full Text] [Related]
23. Oropharyngeal squamous cell carcinoma: a unique disease on the rise?
van Monsjou HS; Balm AJ; van den Brekel MM; Wreesmann VB
Oral Oncol; 2010 Nov; 46(11):780-5. PubMed ID: 20920878
[TBL] [Abstract][Full Text] [Related]
24. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
25. Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.
Ko HC; Harari PM; Sacotte RM; Chen S; Wieland AM; Yu M; Baschnagel AM; Bruce JY; Kimple RJ; Witek ME
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2341-2350. PubMed ID: 28752235
[TBL] [Abstract][Full Text] [Related]
26. The evolving landscape of human papillomavirus-related oropharyngeal squamous cell carcinoma at a single institution in Northern Italy.
Morbini P; Alberizzi P; Ferrario G; Capello G; De Silvestri A; Pedrazzoli P; Tinelli C; Benazzo M
Acta Otorhinolaryngol Ital; 2019 Feb; 39(1):9-17. PubMed ID: 30936574
[TBL] [Abstract][Full Text] [Related]
27. HPV in oropharyngeal cancer: the basics to know in clinical practice.
Elrefaey S; Massaro MA; Chiocca S; Chiesa F; Ansarin M
Acta Otorhinolaryngol Ital; 2014 Oct; 34(5):299-309. PubMed ID: 25709145
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of non-HPV16 genotypes in oropharyngeal squamous cell carcinoma.
Mazul AL; Rodriguez-Ormaza N; Taylor JM; Desai DD; Brennan P; Anantharaman D; Gheit T; Tommasino M; Abedi-Ardekani B; Olshan AF; Zevallos JP
Oral Oncol; 2016 Oct; 61():98-103. PubMed ID: 27688111
[TBL] [Abstract][Full Text] [Related]
29. The "new" head and neck cancer patient-young, nonsmoker, nondrinker, and HPV positive: evaluation.
Deschler DG; Richmon JD; Khariwala SS; Ferris RL; Wang MB
Otolaryngol Head Neck Surg; 2014 Sep; 151(3):375-80. PubMed ID: 24925311
[TBL] [Abstract][Full Text] [Related]
30. Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8
Hladíková K; Koucký V; Bouček J; Laco J; Grega M; Hodek M; Zábrodský M; Vošmik M; Rozkošová K; Vošmiková H; Čelakovský P; Chrobok V; Ryška A; Špíšek R; Fialová A
J Immunother Cancer; 2019 Oct; 7(1):261. PubMed ID: 31623665
[TBL] [Abstract][Full Text] [Related]
31. IGSF4 methylation as an independent marker of human papillomavirus-positive oropharyngeal squamous cell carcinoma.
Chen KM; Stephen JK; Havard S; Mahan M; Divine G; Worsham MJ
JAMA Otolaryngol Head Neck Surg; 2015 Mar; 141(3):257-63. PubMed ID: 25569158
[TBL] [Abstract][Full Text] [Related]
32. Initial presentation of human papillomavirus-related head and neck cancer: A retrospective review.
Khalid MB; Ting P; Pai A; Russo JL; Bakst R; Chai RL; Teng MS; Genden EM; Miles BA
Laryngoscope; 2019 Apr; 129(4):877-882. PubMed ID: 30194702
[TBL] [Abstract][Full Text] [Related]
33. Detection of HPV-associated oropharyngeal tumours in a 16-year cohort: more than meets the eye.
Melchers LJ; Mastik MF; Samaniego Cameron B; van Dijk BA; de Bock GH; van der Laan BF; van der Vegt B; Speel EJ; Roodenburg JL; Witjes MJ; Schuuring E
Br J Cancer; 2015 Apr; 112(8):1349-57. PubMed ID: 25867270
[TBL] [Abstract][Full Text] [Related]
34. HPV-associated head and neck cancer: a virus-related cancer epidemic.
Marur S; D'Souza G; Westra WH; Forastiere AA
Lancet Oncol; 2010 Aug; 11(8):781-9. PubMed ID: 20451455
[TBL] [Abstract][Full Text] [Related]
35. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
[TBL] [Abstract][Full Text] [Related]
36. Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.
Trosman SJ; Koyfman SA; Ward MC; Al-Khudari S; Nwizu T; Greskovich JF; Lamarre ED; Scharpf J; Khan MJ; Lorenz RR; Adelstein DJ; Burkey BB
JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):457-62. PubMed ID: 25742025
[TBL] [Abstract][Full Text] [Related]
37. A model using concomitant markers for predicting outcome in human papillomavirus positive oropharyngeal cancer.
Bersani C; Mints M; Tertipis N; Haeggblom L; Sivars L; Ährlund-Richter A; Vlastos A; Smedberg C; Grün N; Munck-Wikland E; Näsman A; Ramqvist T; Dalianis T
Oral Oncol; 2017 May; 68():53-59. PubMed ID: 28438294
[TBL] [Abstract][Full Text] [Related]
38. Impact of human papillomavirus status on survival and recurrence in a geographic region with a low prevalence of HPV-related cancer: A retrospective cohort study.
De Cicco R; de Melo Menezes R; Nicolau UR; Pinto CAL; Villa LL; Kowalski LP
Head Neck; 2020 Jan; 42(1):93-102. PubMed ID: 31633252
[TBL] [Abstract][Full Text] [Related]
39. Lack of CD44 overexpression and application of concurrent chemoradiotherapy with cisplatin independently indicate excellent prognosis in patients with HPV-positive oropharyngeal cancer.
Biesaga B; Kołodziej-Rzepa M; Janecka-Widła A; Słonina D; Halaszka K; Przewoźnik M; Mucha-Małecka A
Tumour Biol; 2021; 43(1):99-113. PubMed ID: 34024796
[TBL] [Abstract][Full Text] [Related]
40. Individualized survival prediction for patients with oropharyngeal cancer in the human papillomavirus era.
Beesley LJ; Hawkins PG; Amlani LM; Bellile EL; Casper KA; Chinn SB; Eisbruch A; Mierzwa ML; Spector ME; Wolf GT; Shuman AG; Taylor JMG
Cancer; 2019 Jan; 125(1):68-78. PubMed ID: 30291798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
